Xiaoqian Zhang
Fujian Medical University(CN)Bozhou People's Hospital(CN)Second Affiliated Hospital of Fujian Medical University(CN)
Publications by Year
Research Areas
Pancreatic function and diabetes, Liver physiology and pathology, Corporate Finance and Governance, Epigenetics and DNA Methylation, Hepatocellular Carcinoma Treatment and Prognosis
Most-Cited Works
- → Does mixed-ownership reform improve SOEs' innovation? Evidence from state ownership(2020)176 cited
- → Tryptophan derivatives regulate the transcription of Oct4 in stem-like cancer cells(2015)112 cited
- → A novel prognostic model based on single-cell RNA sequencing data for hepatocellular carcinoma(2022)57 cited
- → HINT: a novel prognostic model for patients with hepatitis B virus‐related acute‐on‐chronic liver failure(2018)55 cited
- → Akt-mediated phosphorylation of Oct4 is associated with the proliferation of stem-like cancer cells(2015)48 cited
- → The HDAC Inhibitor Quisinostat (JNJ-26481585) Supresses Hepatocellular Carcinoma alone and Synergistically in Combination with Sorafenib by G0/G1 phase arrest and Apoptosis induction(2018)45 cited